Target intelligence / Profile preview

Nuclear pore associated protein 1 pseudogene 3 (NPAP1P3)

Target: NPAP1P3
Molecular classification: Other (Pseudogene; does not fall within typical classifications like receptor, enzyme, etc.[8])

Overview

Nuclear pore associated protein 1 pseudogene 3 (NPAP1P3) is a processed pseudogene in humans, meaning it is a noncoding DNA sequence that has high homology to the nuclear pore associated protein 1 gene but does not produce a functional protein product. It is typically annotated in genomic databases as a pseudogene and is not considered a therapeutic or diagnostic target. There is no evidence for direct biological or disease relevance of NPAP1P3 itself, though pseudogenes in general may sometimes exert regulatory effects via their RNA transcripts[5][8][2].

Other names: NPAP1P3

Beyond the preview

Go deeper on Nuclear pore associated protein 1 pseudogene 3 (NPAP1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear pore associated protein 1 pseudogene 3 (NPAP1P3).

Explore the full profile